KCT0000542Not yet recruiting未知
Stereotactic ablative radiotherapy for hepatocellular carcinoma with major portal vein invasion: A phase II study
Korea Institute of Radiological & Medical Sciences0 sites28 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Enrollment
- 28
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 18(Year) to o Limit (—)
- Sex
- All
Inclusion Criteria
- •1. Male or female patients =18 years of age
- •2. Eastern Cooerative Oncology Group performance status 0 or 1
- •3. HCC with major portal vein tumor thrombosis (tumor thrombosis in the main portal vein or 1st branch of portal vein)
- •4. Cirrhotic status of Child Pugh class A or B7
- •5. Patients can have extra-hepatic disease; provided the hepatic disease is the highest burden, the extra-hepatic disease is low burden and potentially treatable with radiotherapy, chemotherapy and target agent etc; patient survival is expected to be at least 6 months.
- •6. Patient or gaurdian must be able to provide verbal and written informed consent
Exclusion Criteria
- •1. Prior trans-arterial chemo-embolization =4 after diagnosis of major portal vein tumor thrombosis
- •2. Severe complication caused by liver cirrhosis eg. variceal bleeding, poorly controlled ascites, hepatic encephalopathy)
- •3. Uncontrolled inter-current illness except liver cirrhosis
Investigators
Similar Trials
Completed
Not Applicable
Stereotactic body radiation therapy for hepatocellular carcinoma.Hepatocellular carcinoma.JPRN-UMIN000008502Hiroshima university hospital200
Recruiting
Not Applicable
HEpatocellular carcinoma stereotactic RAdiotherapy CLinical Evaluation StudyC22.0Liver cell carcinomaDRKS00008566niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde75
Withdrawn
Phase 2
Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or TransplantAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver CancerNCT01194206Case Comprehensive Cancer Center
Completed
Phase 2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
Active, not recruiting
Phase 2
High dose Radiation therapy to eradicate early metastatic prostate cancer as an alternative to hormone or chemotherapy: a prospective phase II studyProstate CancerACTRN12618000566235Integrated Clinical Oncology Network Pty Ltd (ICON)208